Literature DB >> 25707781

Therapy. Aptamer-lipid nanoparticle conjugates for RNAi in bone.

Jennifer Sargent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25707781     DOI： 10.1038/nrendo.2015.18

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  Aptamer-functionalized lipid nanoparticles targeting osteoblasts as a novel RNA interference-based bone anabolic strategy.

Authors:  Chao Liang; Baosheng Guo; Heng Wu; Ningsheng Shao; Defang Li; Jin Liu; Lei Dang; Cheng Wang; Hui Li; Shaohua Li; Wing Ki Lau; Yu Cao; Zhijun Yang; Cheng Lu; Xiaojuan He; D W T Au; Xiaohua Pan; Bao-Ting Zhang; Changwei Lu; Hongqi Zhang; Kinman Yue; Airong Qian; Peng Shang; Jiake Xu; Lianbo Xiao; Zhaoxiang Bian; Weihong Tan; Zicai Liang; Fuchu He; Lingqiang Zhang; Aiping Lu; Ge Zhang
Journal:  Nat Med       Date:  2015-02-09       Impact factor: 53.440
  1 in total
  2 in total

1.  EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors.

Authors:  James Saller; Shabnam Seydafkan; Mohammad Shahid; Manoj Gadara; Mauro Cives; Steven A Eschrich; David Boulware; Jonathan R Strosberg; Nasir Aejaz; Domenico Coppola
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

Review 2.  Functional nucleic acid-based hydrogels for bioanalytical and biomedical applications.

Authors:  Juan Li; Liuting Mo; Chun-Hua Lu; Ting Fu; Huang-Hao Yang; Weihong Tan
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.